TENX
TENAX THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.52
+11.76%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.35
- Revenue estimate
- —
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- -$0.35
- EPS estimate
- -$0.38
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +34.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $11
- PT range
- $4.00 – $35
- Analysts
- 6
2 Buy4 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 31, 2026 | -$0.38 | -$0.35 | Beat 8.20% | — |
| May 12, 2026 | -$0.40 | -$0.35 | Beat 12.50% | — |
| Nov 12, 2025 | -$1.33 | -$0.40 | Beat 69.92% | — |
| Aug 13, 2025 | -$0.50 | -$0.27 | Beat 46.00% | — |
| May 14, 2025 | -$0.48 | -$0.28 | Beat 41.67% | — |
| Mar 25, 2025 | -$0.52 | -$0.18 | Beat 65.38% | — |
| Nov 13, 2024 | -$1.38 | -$0.19 | Beat 86.23% | — |
| May 14, 2024 | -$2.40 | -$3.12 | Miss -30.00% | — |
| Nov 13, 2023 | -$7.20 | -$6.40 | Beat 11.11% | — |
| Aug 14, 2023 | -$0.10 | -$4.00 | Miss -3900.00% | — |
| May 15, 2023 | -$0.37 | -$12 | Miss -3143.24% | — |
| Nov 10, 2022 | -$176 | -$176 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026